17:33 , Jul 17, 2018 |  BC Innovations  |  Distillery Therapeutics

Dermatology

INDICATION: Dermal ulcers Mouse studies suggest a laminin peptide-antioxidant conjugate could help treat diabetic foot ulcers. The conjugate consists of a 12-mer peptide derived from LAMA5, which interacts with CD49C/CD29 and other integrins to promote...
23:17 , Sep 29, 2017 |  BioCentury  |  Strategy

Bridge to innovation

While Zai Lab Ltd. has joined the ranks of Chinese biotechs making a splash on NASDAQ, less noticed may be the first wave of China-based players moving into Boston to jump-start their push into novel...
23:00 , Jun 30, 2017 |  BC Extra  |  Company News

Management tracks

Cell therapy play BlueRock Therapeutics (Toronto, Ontario) named Emile Nuwaysir president and CEO, and Robert Deans chief technology officer. Nuwaysir was president and COO at Cellular Dynamics International Inc., which Fujifilm Holdings Corp. (Tokyo:4901) acquired...
19:02 , May 8, 2017 |  BC Innovations  |  Distillery Therapeutics

Dermatology

INDICATION: Wounds Patient sample and mouse studies suggest a topical hydrogel that scavenges MCP-1, CCL3, CCL4 and other inflammatory factors could help treat chronic wounds. The hydrogel consisted of star-shaped PEG (starPEG) and glycosaminoglycans containing heparins...
20:39 , Jan 6, 2017 |  BC Week In Review  |  Financial News

Acelity withdraws IPO

Acelity withdrew its IPO on NYSE, citing market conditions. Acelity filed for an IPO in August 2015. Acelity Holdings Inc., San Antonio, Texas  ...
07:00 , Oct 3, 2016 |  BioCentury  |  Finance

Reasonable rally

Steve Edelson, Senior Editor   It looks like biotech's rebound will continue through the end of the year, but not with enough gusto to match the third quarter, or to make up for losses in the...
07:00 , Sep 19, 2016 |  BC Week In Review  |  Financial News

Acelity completes venture financing

Acelity L.P. Inc., San Antonio, Texas   Business: Dermatology, Dental, Transplant   Date completed: 2016-09-13   Type: Venture financing   Raised: $1.8 billion   Note: The financing comprises senior secured notes, which bear 9.625% interest and mature in 2021. The...
07:00 , Sep 13, 2016 |  BC Extra  |  Company News

Management tracks

Gene therapy company NightstaRx Ltd. (London, U.K.) named Gregory Robinson CSO. He was CSO at Agilis Biotherapeutics LLC (Cambridge, Mass.). Wound care company Acelity L.P. Inc. (San Antonio, Texas) said EVP and CFO Tom Casey...
07:00 , Jul 11, 2016 |  BioCentury  |  Finance

Ground up

Steve Edelson, Senior Editor   As the third quarter gets under way, biotech is shaking off the hangover of the Brexit vote while facing the overhang of the November election in the U.S. Fifteen bankers and...
07:00 , Jun 27, 2016 |  BC Week In Review  |  Financial News

Acelity completes venture financing

Acelity L.P. Inc., San Antonio, Texas   Business: Dermatology, Dental, Transplant   Date completed: 2016-06-17   Type: Venture financing   Raised: $190 million   Investor: Institutional investors   Note: The financing comprises senior secured notes, which bear 7.875% interest and mature...